Loading organizations...
Loading organizations...
QL Biopharma company
QL Biopharma has raised $145.5M across 2 funding rounds.
QL Biopharma has raised $145.5M in total across 2 funding rounds.
QL Biopharma has raised $145.5M in total across 2 funding rounds.
QL Biopharma's investors include OrbiMed, 5Y Capital, Huagai Capital, Qiming Venture Partners, TF Capital.
QL Biopharma has raised $145.5M across 2 funding rounds. Most recently, it raised $72.8M Series C in March 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2026 | $72.8M Series C | OrbiMed | 5Y Capital, Huagai Capital, Qiming Venture Partners, TF Capital |
| $72.8M QL Biopharma Funding Round | OrbiMed |